XOFIGO Drug Patent Profile
✉ Email this page to a colleague
When do Xofigo patents expire, and what generic alternatives are available?
Xofigo is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in XOFIGO is radium ra-223 dichloride. One supplier is listed for this compound. Additional details are available on the radium ra-223 dichloride profile page.
Summary for XOFIGO
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 30 |
Drug Prices: | Drug price information for XOFIGO |
What excipients (inactive ingredients) are in XOFIGO? | XOFIGO excipients list |
DailyMed Link: | XOFIGO at DailyMed |
Recent Clinical Trials for XOFIGO
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GenesisCare USA | Phase 3 |
Bayer | Phase 4 |
Carolina Urologic Research Center | Phase 3 |
Pharmacology for XOFIGO
Drug Class | Radioactive alpha-Particle Emitting Therapeutic Agent |
Mechanism of Action | alpha-Particle Emitting Activity |
US Patents and Regulatory Information for XOFIGO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | XOFIGO | radium ra-223 dichloride | SOLUTION;INTRAVENOUS | 203971-001 | May 15, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for XOFIGO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Hlthcare | XOFIGO | radium ra-223 dichloride | SOLUTION;INTRAVENOUS | 203971-001 | May 15, 2013 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for XOFIGO
See the table below for patents covering XOFIGO around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 69932183 | ⤷ Try a Trial | |
Turkey | 200201442 | ⤷ Try a Trial | |
Norway | 990001 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for XOFIGO
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1140212 | 507 | Finland | ⤷ Try a Trial | |
1140212 | 14C0038 | France | ⤷ Try a Trial | PRODUCT NAME: RADIUM 223 AINSI QUE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES,EN PARTICULIER LE DICHLORURE DE RADIUM 223; REGISTRATION NO/DATE: EU/1/13/873 20131113 |
1140212 | C300666 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: RADIUM-223, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH; REGISTRATION NO/DATE: EU/1/13/873/001 20131113 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |